Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Thymus
|
January 1, 1987
Fetal liver infusion in acute myelogenous leukaemia
V Kochupillai, S Sharma, S Francis, et al.
Thymus
|
January 1, 1987
Fetal liver infusion in aplastic anaemia
V Kochupillai, S Sharma, S Francis, et al.
Autism Research and Treatment
|
March 17, 2016
Factor Structure, Internal Consistency, and Screening Sensitivity of the GARS-2 in a Developmental Disabilities Sample
Martin A Volker, Elissa H Dua, Christopher Lopata, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in <i>NEFL</i>
Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 21, 2025
Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL
Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Thymus
|
January 1, 1987
Fetal liver infusion in acute myelogenous leukaemia
V Kochupillai, S Sharma, S Francis, et al.
Thymus
|
January 1, 1987
Fetal liver infusion in aplastic anaemia
V Kochupillai, S Sharma, S Francis, et al.
Autism Research and Treatment
|
March 17, 2016
Factor Structure, Internal Consistency, and Screening Sensitivity of the GARS-2 in a Developmental Disabilities Sample
Martin A Volker, Elissa H Dua, Christopher Lopata, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in <i>NEFL</i>
Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 21, 2025
Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL
Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Page
of 2